Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes

Peyronnet, B., Brucker, B.M., De Nunzio, C. et al. (6 more authors) (2025) Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes. World Journal of Urology, 43. 514.

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: β3-adrenoceptor agonists; β3-adrenergic receptor agonists; Overactive bladder; Pharmacokinetics; Treatment adherence and compliance; Vibegron
Dates:
  • Accepted: 29 June 2025
  • Published (online): 26 August 2025
  • Published: 26 August 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 02 Sep 2025 15:11
Last Modified: 02 Sep 2025 15:11
Published Version: https://doi.org/10.1007/s00345-025-05799-8
Status: Published
Publisher: Springer Science and Business Media LLC
Refereed: Yes
Identification Number: 10.1007/s00345-025-05799-8
Open Archives Initiative ID (OAI ID):

Export

Statistics